CervoMed CRVO
NASDAQ CRVO
$2.97 +0.09 (+3.12%)
At close: Sep 30, 2026 · 4:00 PM EDT

CervoMed (CRVO) EBITDA Margin (2011 - 2013)

Updated

CervoMed's EBITDA Margin was -11287.77% in Q2 2013, down 8904.25 percentage points from -2383.52% a year earlier.

Analysis

CervoMed (CRVO) EBITDA Margin (2011 - 2013) Analysis & Trends

For FY2012, EBITDA Margin at CervoMed came in at -3141.20%, down 282.26 percentage points from FY2011.

  • In earlier years, EBITDA Margin was -2858.94% in FY2011 (+16020.07 pp) and -18879.01% in FY2010.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 35.95%
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 49.01%
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 6.02%
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 33.11%
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 46.01%
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn -124.26%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 39.16%
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 39.10%
10 CervoMed 29.50 Mn 29.50 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2013 -11,287.77%
Sep 30, 2012 -2,383.52%
Jun 30, 2012 -2,383.52%
Mar 31, 2012 -1,468.13%
Dec 31, 2011 -2,649.82%
Sep 30, 2011 -1,646.06%
API Access

CervoMed EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=CRVO&period=max&api_key=YOUR_API_KEY